Genmab Investor Relations Material
Latest events
M&A Announcement
Genmab
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Genmab
Access all reports
Segment Data
Access more data
Revenue by
Type
Royalties
Milestone revenue
Reimbursement revenue
Collaboration revenue
License revenue
Expenses by
Financials
Genmab, a biotechnology company, develops antibody therapeutics for the treatment of cancer and other diseases primarily in Europe.
Key slides for Genmab
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇩🇰 Denmark